Just eight months after losing the bid for medical-device maker Guidant, Johnson & Johnson is suing Boston Scientific and Abbott Laboratories saying that the two companies intentionally interfered and induced Guidant to breach the deal by leaking confidential information to Abbott to arrange a prepackaged divestiture of Guidant businesses to Abbot.
J&J wanted to purchase Guidant which was one of three companies preparing to put drug-coated stents on the market to give the company entry into the lucrative market for implantable pacemakers and defibrillators.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.